Cutter Capital Management »

Gilead Sciences shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $19M 265k 73.25

More positions owned by Cutter Capital Management

Bristol Myers Squibb (BMY)
Gilead Sciences (GILD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Regeneron Pharmaceuticals (REGN)
BioMarin Pharmaceutical (BMRN)
Ionis Pharmaceuticals (IONS)
Royalty Pharma Shs Class A (RPRX)
Sarepta Therapeutics (SRPT)
ACADIA Pharmaceuticals (ACAD)
Biogen Idec (BIIB)
BioCryst Pharmaceuticals (BCRX)
Halozyme Therapeutics (HALO)
Perrigo SHS (PRGO)
Exelixis (EXEL)
Avadel Pharmaceuticals SHS

View all positions for Cutter Capital Management

Top funds holding Gilead Sciences

BlackRock
Vanguard Group
Dodge & Cox
Geode Capital Management
Wellington Management Company
Morgan Stanley
FMR
Bank of New York Mellon
Northern Trust
Legal & General Group
Dimensional Fund Advisors
Ubs Global Asset Management Americas
Amundi
Nuveen Asset Management
Citadel Advisors

View all funds holding Gilead Sciences